GURUFOCUS.COM » STOCK LIST » Asia » Hong Kong » HKSE » Alphamab Oncology (HKSE:09966) » Definitions » General and Admin. Expense
Switch to:

Alphamab Oncology (HKSE:09966) General and Admin. Expense

: HK$99.6 Mil (TTM As of Jun. 2022)
View and export this data going back to 2019. Start your Free Trial

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Alphamab Oncology's General and Admin. Expense for the six months ended in Jun. 2022 was HK$51.7 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2022 was HK$99.6 Mil.

Alphamab Oncology General and Admin. Expense Historical Data

The historical data trend for Alphamab Oncology's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21
General and Admin. Expense
7.86 34.95 171.69 92.71 94.59

Alphamab Oncology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
General and Admin. Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.41 44.61 46.06 47.90 51.69

Alphamab Oncology General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$99.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alphamab Oncology General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology (HKSE:09966) Business Description

Alphamab Oncology logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » General and Admin. Expense
Comparable Companies
HKSE:02171 HKSE:02257 HKSE:02162 HKSE:01952 HKSE:02616 HKSE:00775 HKSE:01167 HKSE:02137 HKSE:01521 HKSE:01477 OCSE:NOVO B ASX:CSL NAS:REGN NAS:VRTX NAS:MRNA XKRX:207940 NAS:BNTX HKSE:02269 NAS:SGEN SZSE:300122
Traded in Other Exchanges
3NK:Germany
Address
No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024
Website
http://www.alphamabonc.com
Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines